SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micros strong quarterly results and raised full-year outlook, driven by AI-server demand, dominate discussion. Bulls view the results as validation and see the shares as undervalued, while skeptics cite margin, cash-flow and credibility concernsand question the muted stock reaction.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Midterm election results and the prospect of Democrats gaining control of Congress dominate discussion, with traders debating whether a potential setback for Trump would hurt DJT or ease political risk. Bears expect pressure if Republicans lose ground, while some bulls argue the election may be a routine midterm rebuke and point to the stocks rebound.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs stronger-than-expected quarterly results and upbeat outlook, driven by surging AI data-center demand, are fueling a sharp rebound and optimism that semiconductor demand remains strong. Bulls are celebrating the growth outlook and squeeze on bearish bets, while skeptics question the valuation, weaker cash flow, and reliance on data-center expansion.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

A letter from 28 HOPE-3 investigators urging FDA approval of deramiocel has renewed optimism ahead of the agencys Nov. 22 decision for the Duchenne muscular dystrophy therapy. Many traders see the physicians support as strengthening the case for approval and anticipate short covering, while others remain wary of the FDAs prior concerns about the trial data and the binary outcome.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include core, cognitive adjacencies, and cognitive networks. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Aristas quarterly results beat expectations, and its next-quarter guidance came in well above forecasts, with traders pointing to accelerating AI-networking demand as the key driver. The strong report sparked a sharp rally and bullish calls for further gains, though some caution that elevated valuation and volatile post-earnings trading could bring profit-taking.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

Attention centers on Agility Robotics humanoid-robot exposure, with traders comparing it to Unitrees high-profile IPO and citing U.S. restrictions on Chinese robot imports as potential tailwinds. Bulls point to commercial deployments and major backers, while skeptics question the SPAC valuation, limited revenue, and ability to scale.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ chatter centers on a choppy tech-market rebound, with traders crediting strong AMD and SMCI results for renewed buying while debating whether the rally can hold. Midterm-election uncertainty and concerns about AI valuations and tech-sector weakness keep bearish views active.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingos Q3 results and raised full-year guidance are driving discussion: traders point to accelerating user growth and revenue and bookings above expectations, while noting a slight EPS miss. Reactions are split, with optimism that AI can improve the product countered by concerns about monetization, valuation and the shares post-earnings pullback.

Astera Labs, Inc. provides rack-scale AI infrastructure through purpose-built connectivity solutions. The company offers a range of semiconductor-based connectivity solutions designed to address bandwidth, latency, and reliability challenges in AI and cloud data centers. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs strong quarterly results and raised outlook are drawing attention, but shares sold off despite the beat. Traders are debating whether the reaction reflects lofty valuation and concerns about AI-data-center spending or a buying opportunity, with dip-buyers pointing to continued growth in connectivity products.

Block, Inc. engages in creating ecosystems for distinct customer audiences. It operates through the following segments: Square and Cash App. The Square segment provides payment services, software solutions, hardware, and financial services to sellers. The Cash App segment includes the financial tools available to individuals within the mobile Cash App, including peer-to-peer payments, bitcoin and stock investments. The company was founded by Jack Patrick Dorsey and James Morgan McKelvey in February 2009 and is headquartered in Oakland, CA.

Block Inc - Ordinary Shares - Class A

Block Inc

Blocks Q3 earnings beat estimates and the company raised its 2026 profit outlook, drawing bullish calls on growth in Cash App and Square. Skeptics question the quality of the beat, pointing to Bitcoin-related gains, rising credit losses and expenses, while some traders say the shares have failed to sustain the positive reaction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

BSX Stock Looks To Snap 3-Week Winning Streak: Analysts Downgrade Boston Scientific As Cyberattack And Slowing Growth Cloud Outlook

Equity

Boston Scientific’s weak outlook, cyberattack disruptions, and slowing Watchman and electrophysiology growth weighed on sentiment.


The Silver Tsunami: Healthcare ETFs to Buy Amid Aging US Demographics

 ETFs like XLV stand out as aging U.S. demographics fuel rising demand for healthcare, medical devices and senior-focused care. 

Buy the Dip in These Top-Ranked ETFs

Market volatility from Iran tensions has created dip-buying chances. Here are 5 ETFs across tech, semis, dividends, healthcare and financials.

Why Did BFLY Stock Surge More Than 23% Pre-Market Today?

The company posted Q4 revenue of $31.5 million, marking a 41% increase year-on-year (YoY), while the adjusted loss per share (EPS) for the quarter was $0.02.


Why Did GUTS Stock Plummet Today Despite Positive Gut Therapy Midterm Study? 

Six-month data from 40 participants suggest that Revita helps limit weight regain after GLP-1 discontinuation.


iShares Trust - iShares U.S. Medical Devices ETF

Neutral Sentiment

<ul class="summary-bullets"><li>Despite beating Q3 earnings estimates, Boston Scientific faces growth concerns.</li><li>Jefferies downgraded the stock to ‘Hold,’ cutting its price target to $46 from $60.</li><li>JPMorgan downgraded Boston Scientific to ‘Neutral’ and pointed to delayed product programs.&nbsp;&nbsp;&nbsp;</li></ul><p>Boston Scientific Corp. (BSX) stock is on track to reverse a&nbsp; three-week winning streak as Wall Street turns cautious after its third-quarter (Q3) results and a weaker 2026 outlook. Jefferies and JPMorgan downgraded the stock, slashing price targets over cyberattack fallout, slowing product growth and a delayed pipeline that could affect its 2027 performance.&nbsp;</p><p><a href="https://stocktwits.com/symbol/BSX">Boston Scientific stock</a> edged up 0.4% overnight, ahead of Thursday. The stock has fallen more than 7% so far this week.&nbsp;</p><h2 class="st-heading-2">Jefferies Downgrades Boston Scientific As Growth Catalysts Fade</h2><p>Though Boston Scientific’s third-quarter (Q3) earnings beat expectations, concerns about slower business momentum, delayed product development milestones and the lingering effects of a cyber incident have clouded its near-term outlook.</p><p>Jefferies analyst Matthew Taylor cut the medical device maker's stock to ‘Hold’ from ‘Buy’ and slashed his price target to $46 from $60, implying only an 8% upside from the stock’s last closing price.&nbsp;</p><p>The analyst cited uncertainty surrounding pulsed field ablation (PFA) and Watchman products, alongside a challenging business outlook and a limited number of growth drivers expected in 2027. Taylor expects the shares to remain range-bound over the coming quarters, with opportunities for growth only emerging in 2028 and later.</p><h2 class="st-heading-2">JPMorgan Flags Broader Business Concerns For&nbsp;Boston Scientific</h2><p>JPMorgan also took a cautious stance, shifting its rating to ‘Neutral’ from ‘Overweight’ and cutting its price target to $46 from $56. The analyst acknowledged that investors expected adjustments to the company's guidance after a cyber incident in Q3. However, the firm believes the weaker outlook extends beyond conservative financial projections.</p><p>The analyst said Boston Scientific expects slower sales and earnings growth in 2027. Delays in several product development projects also raised concerns about the company’s ability to meet its goals. The company cut its full-year adjusted earnings outlook to $3.16 to $3.18 per share from its prior estimate of $3.28 to $3.32 per share.&nbsp;</p><p>Needham lowered its price target to $48 from $57 but maintained a ‘Buy’ rating. While the cyber incident had already led investors to anticipate weaker guidance, Needham said other developments in the report added to the negative outlook. The disruption is now expected to affect Q4 results as well. Meanwhile, growth in the Watchman business and electrophysiology products weakened again, even after accounting for the cyber-related impact.</p><h2 class="st-heading-2">BSX Stock: Retail View&nbsp;</h2><p>However, on Stocktwits, retail sentiment around the stock flipped to ‘bullish’ from ‘bearish,’ with 1,161% surge in message volume over the past 24 hours.&nbsp;</p><p>A user&nbsp;<a href="https://stocktwits.com/St0ckt0k101/message/667612197">said</a>, “gotta watch for more price cuts!! You know they're coming to bring this down some more. Long and CANNOT sell this low.”</p><p>BSX stock has crashed 55% year-to-date.&nbsp;</p><p>Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-cvna-stock-rising-8-overnight/cZUQO5PR9be">Why Is CVNA Stock Rising 8% Overnight?</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

 In this photo illustration, a smartphone displays the logo of Boston Scientific Corporation.

Boston Scientific Corp. (BSX) stock is on track to reverse a three-week winning streak as Wall Street turns cautious after its third-quarter (Q3) results and a weaker 2026 outlook. Jefferies and JPMorgan downgraded the stock, slashing price targets over c

Feed

News

Sentiment

Fundamentals

Info

IHI iShares US Medical Devices ETF

Fundamentals

Latest IHI News